Evidence map›Paper›PMID 34917234›Full record

ArticleOxidative medicine and cellular longevity2021

Inflammatory Response and Oxidative Stress as Mechanism of Reducing Hyperuricemia of

Lijun Liu, Shengjun Jiang, Xuqiang Liu, Qi Tang, Yan Chen, Jiaojiao Qu, Li Wang, Qiang Wang, Yanli Wang, Jinmei Wang and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Lijun LiuHuaihe Hospital, Henan University, Kaifeng 475004, China.ORCID https://orcid.org/0000-0002-4816-3947
Shengjun JiangNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0001-5440-3073
Xuqiang LiuNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0002-9345-5631
Qi TangNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0002-0903-021X
Yan ChenNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0002-2969-4072
Jiaojiao QuNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0003-2260-043X
Li WangNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0003-0843-8499
Qiang WangNational Health Commission Key Laboratory of Birth Defect Prevention, Henan Institute of Reproductive Health Science and Technology, Zhengzhou 450002, China.ORCID https://orcid.org/0000-0002-7366-5674
Yanli WangNational Health Commission Key Laboratory of Birth Defect Prevention, Henan Institute of Reproductive Health Science and Technology, Zhengzhou 450002, China.ORCID https://orcid.org/0000-0002-1027-5775
Jinmei WangNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0002-3850-1893
Yan ZhangHebei Food Inspection and Research Institute, Shijiazhuang 050091, China.ORCID https://orcid.org/0000-0002-2947-1629
Wenyi KangNational R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004 Henan, China.ORCID https://orcid.org/0000-0002-1822-6249
Henan University · CNNational Health and Family Planning Commission · CNHebei Food Inspection and Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia (HUA) is a metabolic disease, closely related to oxidative stress and inflammatory responses, caused by reduced excretion or increased production of uric acid. However, the existing therapeutic drugs have many side effects. It is imperative to find a drug or an alternative medicine to effectively control HUA. It was reported that

Indexed as

Oxidative StressAnimalsGardeniaHyperuricemiaInflammationKidneyLiverMaleMolecular Docking SimulationNetwork PharmacologyPlant ExtractsRatsRats, Sprague-DawleyUric AcidWolfiporiaPlant ExtractsUric Acid

Identifiers

PMID34917234
PMCPMC8670933
OpenAlexW4200140067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.